SCARB1 Gene Variants Are Associated with the Phenotype of Combined High High-Density Lipoprotein Cholesterol and High Lipoprotein (a)

Circulation: Cardiovascular Genetics

Volumn 9, Issue 5, 2016, Pages 408-418

  Yang, Xiaoping ^a   Sethi, Amar ^b   Yanek, Lisa R ^a   Knapper, Cathy ^b   Nordestgaard, Børge G ^c   Tybjærg Hansen, Anne ^c   Becker, Diane M ^a   Mathias, Rasika A ^a   Remaley, Alan T ^b   Becker, Lewis C ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c Mental Health Services CPH   (Denmark)

Author keywords

Copenhagen City Heart Study; GeneSTAR; high density lipoprotein cholesterol; lipids and lipoproteins; lipoprotein (a); SCARB1 gene variants; SR B1 receptor

Indexed keywords

ARGININE; CHOLESTEROL ESTER; GLUTAMIC ACID; GLYCINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; PROTEIN; SCARB1 PROTEIN; SCAVENGER RECEPTOR BI; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; SCARB1 PROTEIN, HUMAN; SCAVENGER RECEPTOR B;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CODON; EXON; FEMALE; FUNCTIONAL ASSESSMENT; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INTRACELLULAR TRANSPORT; INTRON; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MISSENSE MUTATION; MOUSE; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; RNA STRUCTURE; SPLICE SITE MUTATION; WILD TYPE; ACUTE CORONARY SYNDROME; ATHEROSCLEROSIS; BLOOD; CASE CONTROL STUDY; DENMARK; DYSLIPIDEMIAS; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; HOMOZYGOTE; METABOLISM; RISK FACTOR; UNITED STATES; UPREGULATION;

ACUTE CORONARY SYNDROME; ADULT; AGED; AMINO ACID SUBSTITUTION; ATHEROSCLEROSIS; BIOMARKERS; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; DENMARK; DYSLIPIDEMIAS; EXONS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEK293 CELLS; HOMOZYGOTE; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; MUTATION, MISSENSE; PHENOTYPE; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SCAVENGER RECEPTORS, CLASS B; TRANSFECTION; UNITED STATES; UP-REGULATION;

EID: 84992412655     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.116.001402     Document Type: Article

References (50)

1. Rhainds D, Brissette L, The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. Defining the rules for lipid traders. Int J Biochem Cell Biol 2004 36 39 77
2. Wang N, Arai T, Ji Y, Rinninger F, Tall AR, Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice. J Biol Chem 1998 273 32920 32926
3. Murao K, Terpstra V, Green SR, Kondratenko N, Steinberg D, Quehenberger O, Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes. J Biol Chem 1997 272 17551 17557
4. Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH, Krieger M, Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996 271 518 520
5. Yang XP, Amar MJ, Vaisman B, Bocharov AV, Vishnyakova TG, Freeman LA, Scavenger receptor-BI is a receptor for lipoprotein(a). J Lipid Res 2013 54 2450 2457. doi: 10.1194/jlr.M038877
6. Kozarsky KF, Donahee MH, Glick JM, Krieger M, Rader DJ, Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse. Arterioscler Thromb Vasc Biol 2000 20 721 727
7. Arai T, Wang N, Bezouevski M, Welch C, Tall AR, Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene. J Biol Chem 1999 274 2366 2371
8. Trigatti B, Rayburn H, Viñals M, Braun A, Miettinen H, Penman M, Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc Natl Acad Sci USA 1999 96 9322 9327
9. Huszar D, Varban ML, Rinninger F, Feeley R, Arai T, Fairchild-Huntress V, Increased LDL cholesterol and atherosclerosis in LDL receptor-deficient mice with attenuated expression of scavenger receptor B1. Arterioscler Thromb Vasc Biol 2000 20 1068 1073
10. Acton S, Osgood D, Donoghue M, Corella D, Pocovi M, Cenarro A, Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb Vasc Biol 1999 19 1734 1743
11. Osgood D, Corella D, Demissie S, Cupples LA, Wilson PW, Meigs JB, Genetic variation at the scavenger receptor class B type I gene locus determines plasma lipoprotein concentrations and particle size and interacts with type 2 diabetes: the framingham study. J Clin Endocrinol Metab 2003 88 2869 2879. doi: 10.1210/jc.2002-021664
12. Morabia A, Ross BM, Costanza MC, Cayanis E, Flaherty MS, Alvin GB, Population-based study of SR-BI genetic variation and lipid profile. Atherosclerosis 2004 175 159 168. doi: 10.1016/j.atherosclerosis.2004.03.014
13. Vergeer M, Korporaal SJ, Franssen R, Meurs I, Out R, Hovingh GK, Genetic variant of the scavenger receptor BI in humans. N Engl J Med 2011 364 136 145. doi: 10.1056/NEJMoa0907687
14. Zanoni P, Khetarpal SA, Larach DB, Hancock-Cerutti WF, Millar JS, Cuchel M, CHD Exome+ Consortium; CARDIoGRAM Exome Consortium; Global Lipids Genetics Consortium Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease. Science 2016 351 1166 1171. doi: 10.1126/science.aad3517
15. Utermann G, The mysteries of lipoprotein(a). Science 1989 246 904 910
16. Berglund L, Ramakrishnan R, Lipoprotein(a): an elusive cardiovascular risk factor. Arterioscler Thromb Vasc Biol 2004 24 2219 2226. doi: 10.1161/01.ATV.0000144010.55563.63
17. Gavish D, Azrolan N, Breslow JL, Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene. J Clin Invest 1989 84 2021 2027. doi: 10.1172/JCI114395
18. Trommsdorff M, Köchl S, Lingenhel A, Kronenberg F, Delport R, Vermaak H, A pentanucleotide repeat polymorphism in the 5' control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians. J Clin Invest 1995 96 150 157. doi: 10.1172/JCI118015
19. Lanktree MB, Anand SS, Yusuf S, Hegele RA, SHARE Investigators Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians. Circ Cardiovasc Genet 2010 3 39 46. doi: 10.1161/CIRCGENETICS.109.907642
20. Rader DJ, Mann WA, Cain W, Kraft HG, Usher D, Zech LA, The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans. J Clin Invest 1995 95 1403 1408. doi: 10.1172/JCI117794
21. Reblin T, Niemeier A, Meyer N, Willnow TE, Kronenberg F, Dieplinger H, Cellular uptake of lipoprotein[a] by mouse embryonic fibroblasts via the LDL receptor and the LDL receptor-related protein. J Lipid Res 1997 38 2103 2110
22. Argraves KM, Kozarsky KF, Fallon JT, Harpel PC, Strickland DK, The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor. J Clin Invest 1997 100 2170 2181. doi: 10.1172/JCI119753
23. Blumenthal RS, Becker DM, Yanek LR, Aversano TR, Moy TF, Kral BG, Detecting occult coronary disease in a high-risk asymptomatic population. Circulation 2003 107 702 707
24. Kamstrup PR, Benn M, Tybjaerg-Hansen A, Nordestgaard BG, Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study. Circulation 2008 117 176 184. doi: 10.1161/CIRCULATIONAHA.107.715698
25. Schnohr P, Jensen G, Lange P, Scharling H, Appleyard M, The Copenhagen City Heart Study: tables with data from the third examination, 1991-1994. Eur Heart J 2001 3 suppl H1 H83
26. Marcovina SM, Albers JJ, Gabel B, Koschinsky ML, Gaur VP, Effect of the number of apolipoprotein(a) kringle 4 domains on immunochemical measurements of lipoprotein(a). Clin Chem 1995 41 246 255
27. Sunyaev SR, Eisenhaber F, Rodchenkov IV, Eisenhaber B, Tumanyan VG, Kuznetsov EN, PSIC: profile extraction from sequence alignments with position-specific counts of independent observations. Protein Eng 1999 12 387 394
28. Inazu A, Jiang XC, Haraki T, Yagi K, Kamon N, Koizumi J, Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest 1994 94 1872 1882. doi: 10.1172/JCI117537
29. Zeger SL, Liang KY, Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986 42 121 130
30. Marcovina SM, Albers JJ, Wijsman E, Zhang Z, Chapman NH, Kennedy H, Differences in Lp[a] concentrations and apo[a] polymorphs between black and white Americans. J Lipid Res 1996 37 2569 2585
31. Wahl PW, Warnick GR, Albers JJ, Hoover JJ, Walden CE, Bergelin RO, Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use-The Pacific Northwest Bell Telephone Company health survey. Atherosclerosis 1981 39 111 124
32. Glueck CJ, Gartside P, Laskarzewski PM, Khoury P, Tyroler HA, High-density lipoprotein cholesterol in blacks and whites: potential ramifications for coronary heart disease. Am Heart J 1984 108 3 pt 2 815 826
33. Webb NR, Connell PM, Graf GA, Smart EJ, de Villiers WJ, de Beer FC, SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. J Biol Chem 1998 273 15241 15248
34. Lefévre SH, Chauveinc L, Stoppa-Lyonnet D, Michon J, Lumbroso L, Berthet P, A T to C mutation in the polypyrimidine tract of the exon 9 splicing site of the RB1 gene responsible for low penetrance hereditary retinoblastoma. J Med Genet 2002 39 E21
35. Kozak M, Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6. EMBO J 1997 16 2482 2492. doi: 10.1093/emboj/16.9.2482
36. Constantineau J, Greason E, West M, Filbin M, Kieft JS, Carletti MZ, A synonymous variant in scavenger receptor, class B, type I gene is associated with lower SR-BI protein expression and function. Atherosclerosis 2010 210 177 182. doi: 10.1016/j.atherosclerosis.2009.11.029
37. Maunakea AK, Chepelev I, Cui K, Zhao K, Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition. Cell Res 2013 23 1256 1269. doi: 10.1038/cr.2013.110
38. Schaefer EJ, Zech LA, Jenkins LL, Bronzert TJ, Rubalcaba EA, Lindgren FT, Human apolipoprotein A-I and A-II metabolism. J Lipid Res 1982 23 850 862
39. Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, Krieger M, A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci USA 1997 94 12610 12615
40. Varban ML, Rinninger F, Wang N, Fairchild-Huntress V, Dunmore JH, Fang Q, Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. Proc Natl Acad Sci USA 1998 95 4619 4624
41. Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010 466 707 713. doi: 10.1038/nature09270
42. Kartz GA, Holme RL, Nicholson K, Sahoo D, SR-BI/CD36 chimeric receptors define extracellular subdomains of SR-BI critical for cholesterol transport. Biochemistry 2014 53 6173 6182. doi: 10.1021/bi500706x
43. Connelly MA, Klein SM, Azhar S, Abumrad NA, Williams DL, Comparison of class B scavenger receptors, CD36 and scavenger receptor BI (SR-BI), shows that both receptors mediate high density lipoprotein-cholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake. J Biol Chem 1999 274 41 47
44. Le Jossec M, Wambach T, Labuda D, Sinnett D, Levy E, Genetic diversity patterns in the SR-BI/II locus can be explained by a recent selective sweep. Mol Biol Evol 2004 21 760 769. doi: 10.1093/molbev/msh074
45. Ng DS, Wong NC, Hegele RA, HDL-is it too big to fail? Nat Rev Endocrinol 2013 9 308 312. doi: 10.1038/nrendo.2012.238
46. Tsimikas S, Witztum JL, The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity. Curr Opin Lipidol 2008 19 369 377. doi: 10.1097/MOL.0b013e328308b622
47. Clarke R, Peden JF, Hopewell JC, Kyriakou T, Goel A, Heath SC, PROCARDIS Consortium Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med 2009 361 2518 2528. doi: 10.1056/NEJMoa0902604
48. Seed M, O'Connor B, Perombelon N, O'Donnell M, Reaveley D, Knight BL, The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover. Atherosclerosis 1993 101 61 68
49. Raal FJ, Giugliano RP, Sabatine MS, Koren MJ, Langslet G, Bays H, Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials. J Am Coll Cardiol 2014 63 1278 1288. doi: 10.1016/j.jacc.2014.01.006
50. Armstrong SM, Sugiyama MG, Fung KY, Gao Y, Wang C, Levy AS, A novel assay uncovers an unexpected role for SR-BI in LDL transcytosis. Cardiovasc Res 2015 108 268 277. doi: 10.1093/cvr/cvv218